Drug Trial Radar · NCT07262346
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
138
Actual
Start
Dec 24, 2025
Primary completion
May 28, 2026
Study completion May 28, 2026
Sponsor
- Lead sponsor
- Beijing Continent Pharmaceutical Co, Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- First posted
- Dec 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Based on the Phase I (Ia, Ib, Ic) clinical pharmacokinetic study of Hydronidone Capsules, a clinical pharmacokinetic trial of Hydronidone Capsules (specification: 30 mg/capsule) was conducted, including single-dose administration, multiple-dose administration, and a food-effect study. The aim was to investigate the safety, tolerability, and pharmacokinetic characteristics of higher doses of Hydronidone Capsules (specification: 30 mg/capsule) in healthy subjects, in preparation for future expansion of indications.
Conditions
- Liver Fibrosis
Interventions
Hydronidone capsulesDrug
SAD:Single-dose administration MAD:Multiple-dose group Study on the Interaction between Food and Drugs
Placebo capsulesDrug
SAD:Single-dose administration MAD:Multiple-dose group Study on the Interaction between Food and Drugs
Primary outcomes
What the sponsor says the trial is designed to measure.
- SAD :Blood drug PK parameters(Cmax)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(Tmax)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(AUC0-t)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters( t1/2)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(AUC0-∞)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(λz)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(Vd/F)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(CL/F)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(AUC_%Extrap)Time frame: 24 hours after administration
- SAD:Blood drug PK parameters(MRT)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(ss)Time frame: 24 hours after administration
- MAD :Blood drug PK parameters(Cmax)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(Tmax)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(AUC0-t)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters( t1/2)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(AUC0-∞)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(λz)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(Vd/F)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(CL/F)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(AUC_%Extrap)Time frame: 24 hours after administration
- MAD:Blood drug PK parameters(MRT)Time frame: 24 hours after administration
- The influence of food on the parameters of single-dose pharmacokinetics(Tlag)Time frame: 24 hours after administration
- The influence of food on the parameters of single-dose pharmacokinetics(Cmax)Time frame: 24 hours after administration
- The influence of food on the parameters of single-dose pharmacokinetics(Tmax)Time frame: 24 hours after administration
- The influence of food on the parameters of single-dose pharmacokinetics(AUC0-t)Time frame: 24 hours after administration
- The influence of food on the parameters of single-dose pharmacokinetics(AUC0-∞)Time frame: 24 hours after administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.